Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial

NCT04939311 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding for this trial has not been established.

Conditions

Inflammation
HIV Infection
Cardiovascular Disease

Interventions

DRUG: VB-201
DRUG: Placebo

Sponsor

Priscilla Hsue, MD

Collaborators

[object Object]
[object Object]